Stock futures rose slightly Wednesday ahead of data on U.S. consumer price inflation and quarterly earnings reports from some of the nation's largest banks.

These stocks were poised to make moves Wednesday:

JPMorgan Chase was up 0.3% in premarket trading ahead of fourth-quarter earnings from the largest U.S. bank. Wall Street expects JPMorgan to report earnings of $4.09 a share, up from $3.04 a year earlier. Analysts expect the bank to post net interest income of $23 billion vs. $24.2 billion a year earlier.

Shares of Wells Fargo rose 3.4%. Analysts expect the San Francisco bank to post fourth-quarter profit of $1.35 a share, up from 86 cents in the same period in 2023, and net interest income of $11.7 billion versus $12.8 billion.

Earnings reports are also expected Wednesday Goldman Sachs, Citigroup, BlackRock, and Bank of New York Mellon.

Eli Lilly was down 0.9% in premarket trading after falling 6.6% on Tuesday and finishing as the worst-performing stock in the S&P 500 during the session. Shares fell after the pharmaceutical company reported fourth-quarter sales of blockbuster GLP-1 medicines Zepbound and Mounjaro that missed analysts' estimates.

Microsoft proclaimed Tuesday that 2025 would be the year for its business customers to become " quantum-ready" by preparing their organizations for the eventual technological leap. In a blog post, Microsoft said "we are right on the cusp of seeing quantum computers solve meaningful problems and capture new business value." The statements from the tech giant help boost shares of quantum-computing companies such as D-Wave Quantum, which jumped 18% in premarket trading, and Quantum Computing, which rose 20%.

Applied Digital declined 5.4%. The data-center operator reported a second-quarter adjusted loss of 6 cents a share, narrower than analysts' estimates that called for a loss of 14 cents. Revenue of $63.9 million topped expectations. The stock closed 10% higher on Tuesday after announcing it would receive up to $5 billion from Macquarie Asset Management to help it build artificial-intelligence data centers.

Calavo Growers posted adjusted earnings of 5 cents a share in the fourth quarter, up from a loss of 2 cents a share a year earlier. Sales in the quarter jumped 20% to $170 million. Shares of the avocado and fruit grower were down 4.7%.

Vericel was falling 8.1% after the maker of advanced therapies for the sports medicine and severe burn care markets issued fourth-quarter revenue guidance that missed Wall Street estimates.